Carlington Keith Myers v. HHS - Influenza, Guillain-Barré syndrome (GBS) (2024)

Filed 2020-06-17Decided 2024-12-06Vaccine Influenza
dismissed

Case summary [AI summaries can sometimes make mistakes]

Carlington Keith Myers filed a petition on June 17, 2020, alleging that an influenza vaccine administered on November 23, 2016, caused him to develop Guillain-Barré syndrome (GBS). He also asserted a claim for significant aggravation of a condition.

The respondent, the Secretary of Health and Human Services, filed a motion to dismiss. The Special Master, Chief Special Master Brian H.

Corcoran, found that the petition was not filed within the 36-month statute of limitations. The medical records indicated that Petitioner's neurological symptoms began in May 2017, over five months after his vaccination.

This onset date was more than 36 months prior to the petition's filing date of June 17, 2020. The Special Master also noted that the onset of symptoms fell outside the generally accepted timeframe for GBS claims, even for off-Table ones, which are typically expected within six to eight weeks post-vaccination.

The earliest onset of symptoms was in May 2017, over five months after the November 2016 vaccination. Furthermore, treating physicians considered a prior upper respiratory infection as a potential cause for his GBS.

Due to the untimeliness of the petition and the lack of established causation within a plausible timeframe, the case was dismissed. The public decision does not name Petitioner's counsel or Respondent's counsel, nor does it detail specific clinical findings beyond the diagnoses and symptom progression, or describe the mechanism of GBS causation.

Theory of causation

Petitioner Carlington Keith Myers alleged that an influenza vaccine received on November 23, 2016, caused Guillain-Barré syndrome (GBS) and alternatively, a significant aggravation of a condition. The petition was filed on June 17, 2020. The Special Master, Brian H. Corcoran, dismissed the case, finding it was not filed within the 36-month statute of limitations, as Petitioner's symptoms began in May 2017, over five months after vaccination. The Special Master also determined that the onset of symptoms was outside the typical timeframe for GBS claims, even off-Table ones, which are generally expected within six to eight weeks post-vaccination. Treating physicians considered a prior upper respiratory infection as a potential cause for the GBS. The public decision does not name specific experts or detail a medical theory connecting the vaccine to the GBS, nor does it provide an award amount. The case was dismissed for untimeliness and insufficient evidence of causation.

Source PDFs 1 total · 1 downloaded